Evaluation of O6-methylguanine-DNA methyltransferase by immunohistochemistry: Best clinical and research practices

Pathology Research and Practice

Volumn 207, Issue 8, 2011, Pages 492-497

  Neto, Julio Cirullo ^a   Carvalho, Katia ^a   Olivieri, Eloisa ^a   Carraro, Dirce ^a   Cunha, Isabela ^a   Vassallo, José ^a   Kagohara, Luciane ^a   Soares, Fernando ^a   Rocha, Rafael ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Breast cancer; Immunohistochemistry; MGMT; RT PCR

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; BREAST CARCINOMA; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; ENZYME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MICROSCOPY; MOLECULAR CLONING; PROTEIN EXPRESSION; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAINING; TISSUE MICROARRAY;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PRACTICE GUIDELINES AS TOPIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 80051802257     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.06.003     Document Type: Article

References (16)

1. Brell M., Ibáñez J., Tortosa A. O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction. BMC Cancer 2011, 11:35.
2. Ingold B., Schraml P., Heppner F.L., et al. Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. PLoS ONE 2009, 4:e4775.
3. Kruh G.D. Introduction to resistance to anticancer agents. Oncogene 2003, 22:7262-7264.
4. Mitra S. MGMT: a personal perspective. DNA Repair 1997, 6:1064-1070.
5. Munot K., Bell S.M., Lane S., et al. Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum. Pathol. 2006, 37:989-999.
6. Osanai T., Takagi Y., Toriya Y., et al. Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer. Jpn. J. Clin. Oncol. 2005, 35:121-125.
7. Rhodes A., Jasani B., Balaton A.J., et al. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on 'in house' tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J. Clin. Pathol. 2000, 53:292-301.
8. Rhodes A., Jasani B., Balaton A.J., et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Am. J. Clin. Pathol. 2001, 115:44-58.
9. Rhodes A., Jasani B., Anderson E., et al. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin fixed and paraffin processed cell lines and breast tumours: a comparative study involving results from laboratories in 21 countries. Am. J. Clin. Pathol. 2002, 118:408-417.
10. Rhodes A., Jasani B., Barnes D.M., et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J. Clin. Pathol. 2000, 53:125-130.
11. Rimel B.J., Huettmer P., Powell M.A., et al. Absence of MGMT promoter methylation in endometrial cancer. Gynecol. Oncol. 2009, 112:224-228.
12. Rocha R.M., Nunes C., Rocha G., et al. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol. Res. Prac. 2008, 204:655-662.
13. Rocha R.M., Vassallo J., Soares F., Gobbi H. Digital slides: present status of a tool for consultation, teaching, and quality control in pathology. Pathol. Res. Prac. 2009, 205:735-741.
14. Rocha R.M., Miller K., Soares F., et al. Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer. J. Clin. Pathol. 2009, 62:699-704.
15. Stavrovskaya A.A. Cellular mechanism of multidrug resistance of tumor cells. Biochemistry 2000, 65:95-106.
16. Vasil F.C., Galina I.K., Olga V.Y., et al. Hole of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett. 2006, 231:87-93.